确定关键基因和可能与糖尿病病中维生素D活性干预相关的分子途径
MingXia Zhang1, Mi Tao2, Quan Cao2
1Department of Nephrology, Minda Hospital Affiliated to Hubei Minzu University, Hubei Clinical Research Center for Kidney Disease, Enshi, China.
酸可以通过调节FoxO通路来治疗糖尿病病 (DKD) 纤维化. 在DKD患者中,SUMO3和CD74显示出作为保护脏的生物标志物的潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病病 (DKD) 是晚期功能衰竭的主要原因,治疗选择有限.
- 酸显示出治疗DKD相关纤维化的潜力,但其潜在的分子机制需要阐明.
- 了解醇对DKD纤维化的作用对于开发新型治疗策略至关重要.
研究的目的:
- 为了确定关键的基因和信号通路受到卡尔西醇的影响在DKD相关纤维化.
- 调查酸通过哪些分子机制在DKD中发挥其抗纤维作用.
- 探索潜在的生物标志物来监测DKD进展和酸的治疗疗效.
主要方法:
- 用酸治疗的DKD大鼠脏组织的单细胞基因表达概况.
- 使用孟德尔的随机化和丰富分析 (CIBERSORT,GSVA,GSEA,动机丰富) 分析纤维化相关的细胞子集和基因-免疫细胞相互作用.
- 使用独立数据集和人类蛋白质表达数据验证关键发现.
主要成果:
- 卡尔西醇治疗导致DKD脏组织中的增殖细胞种群减少.
- 已确定FoxO信号通路是DKD中酸调节的关键参与者.
- SUMO3和CD74成为与免疫透,功能 (肌水平,eGFR) 和DKD进展相关的显著标志物.
结论:
- 酸通过FoxO信号通路调节DKD纤维化.
- 在DKD中,SUMO3和CD74代表了对保护的潜在生物标志物.
- 这项研究为糖尿病病的基于酸的治疗策略提供了新的见解.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
相关概念视频
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Dipeptidyl Peptidase 4 Inhibitors
